Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jennifer R. Garreau"'
Autor:
Thomas L. Sutton, Ranish Patel, Shay Behrens, Issac Schwantes, Connor Fewel, Stuart K. Gardiner, Nathalie Johnson, Jennifer R. Garreau
Publikováno v:
The American Journal of Surgery. 225:861-865
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d19fbc7e25d334de5ccb7a0955c6de6b
https://doi.org/10.1016/j.amjsurg.2023.02.020
https://doi.org/10.1016/j.amjsurg.2023.02.020
Autor:
Stuart K. Gardiner, Catherine L Wetzel, Maryam Farinola, Jennifer R. Garreau, Nathalie A. Johnson, Thomas L. Sutton
Publikováno v:
Journal of Surgical Oncology. 124:1224-1234
Background Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer are treated with trastuzumab-based neoadjuvant therapy (NAT); some patients with residual disease post-NAT show loss of HER2 amplification and has been in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783b5cf6a097466dcf3375561406309f
https://doi.org/10.1002/jso.26646
https://doi.org/10.1002/jso.26646
Autor:
Nathalie Johnson, Alexander Schlitt, Jennifer R. Garreau, Thomas L. Sutton, Stuart K. Gardiner
Publikováno v:
Journal of Surgical Oncology. 122:1761-1769
The impact of length of time to surgery (TTS) on oncologic outcomes following neoadjuvant chemotherapy (NAC) in breast cancer patients is unclear. We investigated the relationship between TTS on residual cancer burden (RCB) score and oncologic outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24b06d3b294818f00534a27732333ec
https://doi.org/10.1002/jso.26216
https://doi.org/10.1002/jso.26216
Publikováno v:
The American Journal of Surgery. 217:848-850
Introduction National Comprehensive Cancer Network (NCCN) guidelines currently recommend excisional biopsy for atypical ductal hyperplasia (ADH) diagnosed on core needle biopsy (CNB) due to the possibility of pathologic upgrade to breast cancer upon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b763e70b7e07f4173e758c041d5c0299
https://doi.org/10.1016/j.amjsurg.2018.12.020
https://doi.org/10.1016/j.amjsurg.2018.12.020
Autor:
Thomas L. Sutton, Nathalie Johnson, Alexander Schlitt, Stuart K. Gardiner, Jennifer R. Garreau
Publikováno v:
American journal of surgery. 219(5)
Neoadjuvant chemotherapy (NAC) is increasingly used in the treatment of breast cancer. The time interval from last dose of cytotoxic chemotherapy to surgery (TTS) can vary widely. We aimed to evaluate the effect of TTS on postoperative complications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b2f7f92fb070c9db852754ea70b2c2
https://pubmed.ncbi.nlm.nih.gov/32200974
https://pubmed.ncbi.nlm.nih.gov/32200974
Publikováno v:
American journal of surgery. 215(5)
Background In 2009, the United States Preventive Services Task Force changed the recommended starting age for annual screening mammography from 40 to 50 for non-“high risk” women. In 2015, the American Cancer Society issued similar guidelines, wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca993e4157f77b16173cfe522a69a95c
https://pubmed.ncbi.nlm.nih.gov/29336818
https://pubmed.ncbi.nlm.nih.gov/29336818
Autor:
Laura Bennetts, Leslie Sorenson, Deb Blanchard, William D. Johnson, Nathalie A. Johnson, Margie Glissmeyer, Sally Bryn, Karen Winter, Jennifer R. Garreau
Publikováno v:
The American Journal of Surgery. 207:698-701
Background Both MRI and breast-specific gamma imaging are tools for surgical planning in newly diagnosed breast cancer. Breast-specific gamma imaging (BSGI) is used less frequently although it is of similar utility and lower cost. We compared the dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9787e4d8eec9fa5744f5054ed30048de
https://doi.org/10.1016/j.amjsurg.2013.12.015
https://doi.org/10.1016/j.amjsurg.2013.12.015
Autor:
Jennifer R. Garreau, Brett LaFleur, Su Ellen J. Pommier, Rodney F. Pommier, Patrick Muller, Dara Christante
Publikováno v:
The American Journal of Surgery. 196:505-511
Background We previously reported that breast cancer patients who used hormone replacement therapy (HRT) had significantly lower stage tumors and higher survival than never-users. We present an update with longer follow-up, HRT use data, and in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81dc73e5b9e23b8dafa1d567e81ea577
https://doi.org/10.1016/j.amjsurg.2008.06.023
https://doi.org/10.1016/j.amjsurg.2008.06.023
Autor:
Diana Mahin, Louis Homer, Regan M. Look, Joanne Nelson, Jennifer R. Garreau, Nathalie Johnson, Deb Walts
Publikováno v:
The American Journal of Surgery. 189:610-615
Background The understanding of lobular carcinoma in situ (LCIS) has evolved since it was first described. LCIS once was thought to be a premalignant condition, but now it is considered a marker for increased risk for developing invasive breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e473f561158a99d4fe8973fdf1437f
https://doi.org/10.1016/j.amjsurg.2005.01.032
https://doi.org/10.1016/j.amjsurg.2005.01.032
Autor:
Stuart A. Aaronson, Corinne L. Reimer, Sam W. Lee, Siavash K. Kurdistani, Ana M. Borras, Jennifer R. Garreau, Mirra Chung
Publikováno v:
Journal of Biological Chemistry. 274:11022-11029
Cyclin G, a recent addition to the cyclin family, was initially identified in screens for new src kinase family members and soon thereafter by differential screening for transcriptional targets of the tumor suppressor gene, p53. We have identified cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2f12ac001052e31298d014b52697d4
https://doi.org/10.1074/jbc.274.16.11022
https://doi.org/10.1074/jbc.274.16.11022